MedPath

ongitudinal Preterm Outcome Project, growth, health and development during adolescence

Completed
Conditions
groei en ontwikkeling
prematurity
10028920
10009841
Registration Number
NL-OMON45530
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
332
Inclusion Criteria

- member of the existing Pinkeltje (LOLLIPOP) cohort
- born in the three Northern provinces of the Netherlands;
- written informed consent from the child and both parents.

Exclusion Criteria

none

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Main study endpoint will be the total IQ measured by the Wechsler Intelligence<br /><br>Scale for Children-Third Edition-Dutch Version (WISC-III-NL), with subdivision<br /><br>into verbal and performance IQ, for MLP compared to FT and EP children.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes regard neuropsychological development measured by a series<br /><br>of tests and questionnaires, pubertal development measured by assessment and<br /><br>questionnaire, anthropometry by assessment, and reported health-related<br /><br>behaviors, health literacy, social relations, time spending, school<br /><br>performance, pain perception, and perceived health.</p><br>
© Copyright 2025. All Rights Reserved by MedPath